Evidence map›Paper›PMID 29297237›Full record

ArticleInnate immunity2018

Species-specific differences in regulation of macrophage inflammation by the C3a-C3a receptor axis.

Tathagat Dutta Ray, Samrawit Mekasha, Yanmei Liang, Bao Lu, Sanjay Ram, Robin R Ingalls

Open access · hybridAbstract read
In one paragraph

Article in Innate immunity, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Tathagat Dutta Ray1 Section of Infectious Diseases, Department of Medicine, Boston Medical Center and Boston University School of Medicine, Boston, MA, USA.
Samrawit Mekasha1 Section of Infectious Diseases, Department of Medicine, Boston Medical Center and Boston University School of Medicine, Boston, MA, USA.
Yanmei Liang1 Section of Infectious Diseases, Department of Medicine, Boston Medical Center and Boston University School of Medicine, Boston, MA, USA.
Bao Lu2 1862 Division of Pulmonary and Respiratory Disease, Boston Children's Hospital , Harvard Medical School, Boston, MA, USA.
Sanjay Ram3 Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA.
Robin R Ingalls1 Section of Infectious Diseases, Department of Medicine, Boston Medical Center and Boston University School of Medicine, Boston, MA, USA.
Boston University · USBoston Medical Center · USHarvard University · USUniversity of Massachusetts Chan Medical School · US

Funding

Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI LARRY K BROWN · 1998 to 2026
$51.7M
The TLR4/MD-2 signaling pathway in gonoccocal diseaseU19AI084048 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MADICO, GUILLERMO · 2009 to 2013
$13.1M
Multidisciplinary Training in Cardiovascular ResearchT32HL007224 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI HAMBURG, NAOMI MIRIAM, WAINFORD, RICHARD DAVID · 1985 to 2020
$12.3M
Immune defenses against Neisseria gonorrhoeaeR01AI114790 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI RAM, SANJAY, RICE, PETER A. · 2015 to 2019
$3.1M
Vaccines and Immunotherapeutics against gonorrhea in the contex of Chlamydia coU01AI118161 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI RAM, SANJAY · 2014 to 2017
$2.0M
NHLBI NIH HHS T32 HL007224NIAID NIH HHS P30 AI042853NIAID NIH HHS R01 AI114790NIAID NIH HHS U01 AI118161NIAID NIH HHS U19 AI084048
6 · The paper itself

Abstract

Complement is an important arm of the innate immune system. Recent studies have shown that products of complement pathway activation can interact directly with other innate immune signaling molecules, including TLRs and inflammasome family members, during some infectious and chronic inflammatory disorders. Activation of the complement system generates anaphylatoxins, such as C3a and C5a, which modulate inflammation. However, the biological effects of interactions between the anaphylatoxins with their receptors may vary across species. In this study, we demonstrate that human complement and rat complement differ in the way they modulate the inflammatory response to the human pathogen, Neisseria gonorrhoeae, as well as purified pathogen-associated ligands, such as LPS. While rat serum down-regulates MyD88-dependent pro-inflammatory cytokine responses in macrophages, human serum has no effect, or in some cases an enhancing effect. Further, the inhibitory effect of rat serum on otherwise pro-inflammatory stimuli is mediated by complement, specifically C3a-C3a receptor interactions, via an undefined signaling mechanism that down-regulates the transcription factor, NF-κB and NLRP3 inflammasome-mediated caspase-1 activation. This study highlights important functional differences between rodent and human complement that could explain some of the differences in immune responses between these two species. Understanding the crosstalk between complement and other arms of the innate immune system will facilitate the development of better anti-inflammatory therapeutics.

Indexed as

AnimalsComplement ActivationComplement C3aCytokinesGonorrheaHumansInflammationLipopolysaccharidesMacrophagesMyeloid Differentiation Factor 88Neisseria gonorrhoeaeNF-kappa BNLR Family, Pyrin Domain-Containing 3 ProteinRats, Sprague-DawleySignal TransductionSpecies SpecificityComplement C3aCytokinesLipopolysaccharidesMYD88 protein, humanMyd88 protein, ratMyeloid Differentiation Factor 88NF-kappa BNLR Family, Pyrin Domain-Containing 3 ProteinNLRP3 protein, humanNlrp3 protein, ratCell signalingcomplementinnate immunityLPSNeisseria gonorrhoeae

Identifiers

PMID29297237
PMCPMC6818254
OpenAlexW2781559966

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.